NT

Nilay Thakar

ARCH Venture Partners

Cambridge, Massachusetts

Investor
VC

Invests in

Stages:

Series A
Seed

Sectors:

BioTech

Locations:

United States

  • Min Investment:

    $50,000.00

  • Max Investment:

    $150,000,000.00

  • Target Investment:

    $25,000,000.00

Education

Lists including Nilay

AP
AO
AS
AN

Based in UK

1884 people

AM
AR
AB
AF

Based in Boston & Cambridge

668 people

AT
AS
AT
AH

All Series A Investors

14748 people

AM
AT
AS
AR

All Seed Investors

19691 people

Work Experience

AV
ARCH Venture Partners

2017

  • Principal

    2017

SB
Skylark Bio

2021

  • Co-Founder and Head of BD

    2021

LI
Lifordi Immunotherapeutics, Inc.

2023

  • Board Observer

    2023

AB
Arbor Biotechnologies

2021

  • Board Observer

    2021

VT
Volastra Therapeutics

2022

  • Board Observer

    2022

S
SonoThera

2022

  • Board Observer

    2022

Doppler Bio

2023 - 2025

  • Board Observer

    2023 - 2025

hB
hC Bioscience, Inc.

2022 - 2025

  • Board Observer

    2022 - 2025

IS
International Society for Stem Cell Research

2019 - 2023

  • Committee Member - Industry

    2019 - 2023

AI
Australian Institute for Bioengineering and Nanotechnology AIBN

2014 - 2016

  • General Manager - Stem Cells Ltd

    2014 - 2016